Circulating MKRN3 Levels Decline During Puberty in Healthy Boys

J Clin Endocrinol Metab. 2016 Jun;101(6):2588-93. doi: 10.1210/jc.2016-1488. Epub 2016 Apr 8.

Abstract

Context: Initiation and progression of puberty requires concerted action of hypothalamic activating and inhibiting factors. Recently, cases of familial central precocious puberty have been linked to loss-of-function mutations of makorin RING-finger protein 3 (MKRN3) indicating a pivotal inhibitory role of the protein on GnRH secretion.

Objective: To investigate peripubertal circulating MKRN3 levels in healthy boys.

Design: Population-based longitudinal study in healthy Danish boys.

Setting: General community.

Patients or other participants: Healthy boys (n = 60) aged (median [range]) 9.3 (5.8-11.8) years at baseline followed for 6.0 (0.5-7.6) years (2006-2014) with blood sampling every 6 months.

Intervention: None.

Main outcome measures: Serum levels of MKRN3: 623 samples, median (range) 12 (2-14) per boy.

Results: MKRN3 levels declined before onset of puberty; the geometric mean (95% confidence interval) 5 years before onset of puberty vs last visit before onset of puberty was 216 (169-272) pg/mL vs 128 (118-139) pg/mL (P < .001), respectively. MKRN3 levels continued to decrease as puberty progressed. MKRN3 levels were not associated with age at onset of puberty.

Conclusion: Declining MKRN3 before pubertal onset support MKRN3 as an inhibitor of GnRH secretion during midchildhood.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Healthy Volunteers
  • Humans
  • Longitudinal Studies
  • Male
  • Puberty / blood*
  • Ribonucleoproteins / blood*
  • Ubiquitin-Protein Ligases

Substances

  • Ribonucleoproteins
  • MKRN3 protein, human
  • Ubiquitin-Protein Ligases